NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Spotlight Shifts to Quietly Performing Stocks

On May 4, a market lacking fresh triggers saw several stocks quietly capture attention, driven by price action, technical breakouts, and sustained buying momentum. This trend is characterized by stocks trading above their key short- to medium-term moving averages, indicating a positive trend in the near term.

Dar Credit is currently priced at Rs 41.00, registering a sharp gain of 7.84%. The stock is trading above its 30-day moving average of 38.02, as well as its 50-day (40.90), suggesting improving momentum. However, it is still below its longer-term averages.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
Dar CreditRs 41.007.84%Rs 38.02Rs 40.90

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Dr Lal PathLabs is trading at Rs 1,468.60, up 6.99% for the session. The stock is comfortably above its 30-day (1,372.66) and 50-day (1,380.68) moving averages, indicating short-term strength, and is approaching its longer-term averages of 150-day (1,462.43) and 200-day (1,495.34), reflecting a steady recovery trend.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
Dr Lal PathLabsRs 1,468.606.99%Rs 1,372.66Rs 1,380.68

JHS Svendgaard Laboratories is priced at Rs 20.90, gaining 4.66%. The stock is trading above its 30-day (19.97), but remains below its 150-day (26.28) and 200-day (29.14) levels, suggesting short-term strength but a still weak longer-term trend.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
JHS Svendgaard LaboratoriesRs 20.904.66%Rs 19.97-

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Nidan Laboratories and Healthcare is trading at Rs 13.75, down 7.59%. The stock is below its 30-day moving average of 14.88, as well as its 50-day (15.55), 150-day (17.68), and 200-day (18.25) levels, suggesting sustained weakness across both short- and long-term trends.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
Nidan Laboratories and HealthcareRs 13.75-7.59%Rs 14.88Rs 15.55

Sun TV Network is priced at Rs 577.50, declining 4.40%. It is trading below its 30-day (604.05) and 50-day (599.23) moving averages, indicating short-term bearishness. However, it remains slightly above its 150-day (573.22) and 200-day (571.70) averages, which may offer some support at lower levels.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
Sun TV NetworkRs 577.50-4.40%Rs 604.05Rs 599.23

The Byke Hospitality is trading at Rs 35.07, down 2.42%. The stock is hovering around its 30-day moving average of 35.94 but remains well below its 50-day (39.05), 150-day (51.25), and 200-day (57.04) levels, indicating continued pressure and a weak broader trend.

StockCurrent PriceGain/Loss (%)30-Day Moving Average50-Day Moving Average
The Byke HospitalityRs 35.07-2.42%Rs 35.94Rs 39.05

A few stocks saw sharp intraday moves and hit upper circuits, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment. Notable gainers included Aster DM Health, Schneider Infra, Bajaj Auto, CESC, Laurus Labs, Bandhan Bank, HFCL, BHEL, Adani Ports, Aarti Industries, Siemens, MCX India, Lloyds Metals, Adani Power, Hitachi Energy, GE Shipping, and Sona BLW.

Investor Takeaway

Investors should consider stocks with strong upward momentum and trading above key moving averages.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.